Gennex Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	524.18	75.89	202.31	142.13	74.91
Short-Term Investments	-	470	400	-	-
Cash & Short-Term Investments	524.18	545.89	602.31	142.13	74.91
Cash Growth	-3.98%	-9.37%	323.77%	89.74%	3750.73%
Accounts Receivable	435.57	141.61	178.11	94.17	113.13
Other Receivables	-	25.49	12.13	3.02	8.06
Receivables	435.57	225.92	224.45	122.2	121.2
Inventory	538.88	359.4	251.75	156.92	77.37
Prepaid Expenses	-	2.59	3.46	2.43	0.98
Other Current Assets	1,148	677.49	536.16	63.13	197.36
Total Current Assets	2,647	1,811	1,618	486.83	471.82
Property, Plant & Equipment	711.14	618.25	550.24	676.46	136.98
Long-Term Investments	0.1	0.1	0.1	0.1	68.27
Other Intangible Assets	29.41	29.41	29.41	61.08	-
Long-Term Deferred Tax Assets	-	1.76	2.31	1.37	-
Long-Term Deferred Charges	90.85	90.85	90.85	90.85	-
Other Long-Term Assets	8.7	8.7	8.82	6.47	3.19
Total Assets	3,487	2,560	2,300	1,323	680.27
Accounts Payable	202.99	131.59	151.8	70.78	77.41
Accrued Expenses	12.71	5.9	4.53	6.11	6.32
Short-Term Debt	-	64.01	23.73	5.29	101.24
Current Portion of Long-Term Debt	359.54	38.18	33.47	5.25	-
Current Income Taxes Payable	84.62	77.69	52.6	33.8	20.81
Other Current Liabilities	64.14	128.18	136.92	173.91	36.31
Total Current Liabilities	723.99	445.55	403.05	295.13	242.08
Long-Term Debt	434.07	168.93	132.16	162.88	-
Long-Term Deferred Tax Liabilities	0.33	-	-	-	0.03
Other Long-Term Liabilities	-0	0	-	-	-
Total Liabilities	1,158	614.48	535.21	458.01	242.11
Common Stock	242.95	227.45	227.45	180.19	126.5
Additional Paid-In Capital	-	1,002	1,002	310.7	60
Retained Earnings	-	568.41	405.36	303.35	242.4
Comprehensive Income & Other	1,982	68.79	68.79	9.25	9.25
Total Common Equity	2,225	1,867	1,704	803.5	438.15
Minority Interest	103.16	79	60.83	61.65	-
Shareholders' Equity	2,328	1,946	1,765	865.15	438.15
Total Liabilities & Equity	3,487	2,560	2,300	1,323	680.27
Total Debt	793.61	271.12	189.37	173.42	101.24
Net Cash (Debt)	-269.43	274.78	412.94	-31.28	-26.33
Net Cash Growth	-	-33.46%	-	-	-
Net Cash Per Share	-0.98	1.19	1.91	-0.20	-0.21
Filing Date Shares Outstanding	242.96	227.45	227.45	176.64	126.5
Total Common Shares Outstanding	242.96	227.45	227.45	176.64	126.5
Working Capital	1,923	1,366	1,215	191.7	229.74
Book Value Per Share	9.16	8.21	7.49	4.55	3.46
Tangible Book Value	2,196	1,837	1,674	742.41	438.15
Tangible Book Value Per Share	9.04	8.08	7.36	4.20	3.46
Land	-	118.15	109.97	114.84	84.18
Buildings	-	134.63	120.28	165.4	20.26
Machinery	-	442.8	406.79	482.89	201.7
Construction In Progress	-	52.17	23.25	0.21	-